NM_018685.5:c.1852G>C
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 4P and 1B. PM2PM5BP4
The NM_018685.5(ANLN):c.1852G>C(p.Gly618Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00000137 in 1,461,234 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G618C) has been classified as Pathogenic.
Frequency
Consequence
NM_018685.5 missense
Scores
Clinical Significance
Conservation
Publications
- focal segmental glomerulosclerosis 8Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ANLN | NM_018685.5 | c.1852G>C | p.Gly618Arg | missense_variant | Exon 10 of 24 | ENST00000265748.7 | NP_061155.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ANLN | ENST00000265748.7 | c.1852G>C | p.Gly618Arg | missense_variant | Exon 10 of 24 | 1 | NM_018685.5 | ENSP00000265748.2 | ||
| ANLN | ENST00000396068.6 | c.1741G>C | p.Gly581Arg | missense_variant | Exon 9 of 23 | 1 | ENSP00000379380.2 | |||
| ANLN | ENST00000428612.5 | c.96-5083G>C | intron_variant | Intron 1 of 8 | 5 | ENSP00000413522.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000799 AC: 2AN: 250348 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461234Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726926 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 618 of the ANLN protein (p.Gly618Arg). This variant is present in population databases (no rsID available, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with ANLN-related conditions. Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt ANLN protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at